SciRhom

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

FF Pharmaceuticals

This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.

ILAb

This company develops small-molecule immune response modulating drugs for the treatment of rheumatoid arthritis and related autoimmune diseases for patients.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

Bionyra

This biopharmaceutical company develops monoclonal and bispecific antibodies for patients with severe immune-mediated inflammatory diseases, specifically inflammatory bowel disease and atopic dermatitis.

Aeglea BioTherapeutics

This company develops antibody therapies for patients living with inflammatory bowel disease and other immune-mediated conditions.

Citryll

This company develops therapeutic antibodies targeting neutrophil extracellular traps for patients with immune-mediated inflammatory diseases such as rheumatoid arthritis and hidradenitis suppurativa.

CheckmAb

This biotechnology company develops monoclonal antibody therapies for cancer and autoimmune disease patients by targeting regulatory T cells within pathological tissues.